Anthony J Weier

Array ( [id] => 4006036 [patent_doc_number] => 05859196 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'P30 peptides of Toxoplasma gondii' [patent_app_type] => 1 [patent_app_number] => 8/461296 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5872 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/859/05859196.pdf [firstpage_image] =>[orig_patent_app_number] => 461296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4151109 [patent_doc_number] => 06156305 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Implanted tumor cells for the prevention and treatment of cancer' [patent_app_type] => 1 [patent_app_number] => 8/462252 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 13411 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156305.pdf [firstpage_image] =>[orig_patent_app_number] => 462252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3920675 [patent_doc_number] => 05876708 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Allogeneic and xenogeneic transplantation' [patent_app_type] => 1 [patent_app_number] => 8/458720 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 14 [patent_no_of_words] => 30607 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/876/05876708.pdf [firstpage_image] =>[orig_patent_app_number] => 458720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3868832 [patent_doc_number] => 05837672 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Methods and compositions for the detection of soluble .beta.-amyloid peptide' [patent_app_type] => 1 [patent_app_number] => 8/456347 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12709 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837672.pdf [firstpage_image] =>[orig_patent_app_number] => 456347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4108951 [patent_doc_number] => 06057298 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'Keratin K1 expression vectors and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/452872 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 27926 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/057/06057298.pdf [firstpage_image] =>[orig_patent_app_number] => 452872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3982431 [patent_doc_number] => 05861310 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-19 [patent_title] => 'Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor' [patent_app_type] => 1 [patent_app_number] => 8/456104 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 9 [patent_no_of_words] => 17351 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/861/05861310.pdf [firstpage_image] =>[orig_patent_app_number] => 456104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4209339 [patent_doc_number] => 06110458 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Cancer therapy utilizing ex vivo gene transduction' [patent_app_type] => 1 [patent_app_number] => 8/450011 [patent_app_country] => US [patent_app_date] => 1995-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12004 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110458.pdf [firstpage_image] =>[orig_patent_app_number] => 450011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4307841 [patent_doc_number] => 06187991 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Transgenic animal models for type II diabetes mellitus' [patent_app_type] => 1 [patent_app_number] => 8/446935 [patent_app_country] => US [patent_app_date] => 1995-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 9 [patent_no_of_words] => 7881 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187991.pdf [firstpage_image] =>[orig_patent_app_number] => 446935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3851599 [patent_doc_number] => 05705151 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => 'Gene therapy for T cell regulation' [patent_app_type] => 1 [patent_app_number] => 8/446918 [patent_app_country] => US [patent_app_date] => 1995-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17201 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705151.pdf [firstpage_image] =>[orig_patent_app_number] => 446918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4002445 [patent_doc_number] => 05858963 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Inducing xenograft tolerance and porcine cytokines therefor' [patent_app_type] => 1 [patent_app_number] => 8/436890 [patent_app_country] => US [patent_app_date] => 1995-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 32 [patent_no_of_words] => 17537 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858963.pdf [firstpage_image] =>[orig_patent_app_number] => 436890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3779614 [patent_doc_number] => 05817911 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Transgenic mice expressing alveolar MCP-1' [patent_app_type] => 1 [patent_app_number] => 8/420001 [patent_app_country] => US [patent_app_date] => 1995-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 10252 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817911.pdf [firstpage_image] =>[orig_patent_app_number] => 420001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4242258 [patent_doc_number] => 06091001 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'Production of antibodies using Cre-mediated site-specific recombination' [patent_app_type] => 1 [patent_app_number] => 8/412777 [patent_app_country] => US [patent_app_date] => 1995-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12597 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/091/06091001.pdf [firstpage_image] =>[orig_patent_app_number] => 412777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3866535 [patent_doc_number] => 05837520 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Method of purification of viral vectors' [patent_app_type] => 1 [patent_app_number] => 8/400793 [patent_app_country] => US [patent_app_date] => 1995-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 8706 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837520.pdf [firstpage_image] =>[orig_patent_app_number] => 400793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3705559 [patent_doc_number] => 05675063 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Immortalized rabbit hybridoma fusion partner' [patent_app_type] => 1 [patent_app_number] => 8/396383 [patent_app_country] => US [patent_app_date] => 1995-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6569 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/675/05675063.pdf [firstpage_image] =>[orig_patent_app_number] => 396383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4002251 [patent_doc_number] => 06004811 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => 'Redirection of cellular immunity by protein tyrosine kinase chimeras' [patent_app_type] => 1 [patent_app_number] => 8/394912 [patent_app_country] => US [patent_app_date] => 1995-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 19 [patent_no_of_words] => 19500 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/004/06004811.pdf [firstpage_image] =>[orig_patent_app_number] => 394912 [rel_patent_id] =>[rel_patent_doc_number] =>)